T
Takeshi Hasegawa
Researcher at Showa University
Publications - 104
Citations - 3439
Takeshi Hasegawa is an academic researcher from Showa University. The author has contributed to research in topics: Dialysis & Hemodialysis. The author has an hindex of 26, co-authored 92 publications receiving 2790 citations. Previous affiliations of Takeshi Hasegawa include Kyoto University & Toshiba.
Papers
More filters
Journal ArticleDOI
Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study
Jean Ethier,David C. Mendelssohn,Stacey J. Elder,Takeshi Hasegawa,Tadao Akizawa,Takashi Akiba,Bernard Canaud,Ronald L. Pisoni +7 more
TL;DR: Patients consistently were less likely to use an AVF versus other VA types if female, of older age, having greater body mass index, diabetes, peripheral vascular disease or recurrent cellulitis/gangrene, and countries with a greater prevalence of diabetes in HD patients had a significantly lower percentage of patients using anAVF.
Journal ArticleDOI
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)
Shigeru Nakai,Yuzo Watanabe,Ikuto Masakane,Atsushi Wada,Tetsuo Shoji,Takeshi Hasegawa,Hidetomo Nakamoto,Kunihiro Yamagata,Junichiro James Kazama,Naohiko Fujii,Noritomo Itami,Toshio Shinoda,Takashi Shigematsu,Seiji Marubayashi,Osamu Morita,Seiji Hashimoto,Kazuyuki Suzuki,Naoki Kimata,Norio Hanafusa,Kenji Wakai,Takayuki Hamano,Satoshi Ogata,Kenji Tsuchida,Masatomo Taniguchi,Hiroshi Nishi,Kunitoshi Iseki,Yoshiharu Tsubakihara +26 more
TL;DR: A nationwide statistical survey of 4255 dialysis facilities was conducted at the end of 2011 and the results included questions related to the Great East Japan Earthquake, which occurred on 11 March 2011.
Journal ArticleDOI
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
Csaba P. Kovesdy,Csaba P. Kovesdy,Kunihiro Matsushita,Yingying Sang,Nigel J. Brunskill,Juan Jesus Carrero,Gabriel Chodick,Takeshi Hasegawa,Hiddo J.L. Heerspink,Atsushi Hirayama,Gijs W D Landman,Adeera Levin,Dorothea Nitsch,David C. Wheeler,Josef Coresh,Stein Hallan,Varda Shalev,Morgan E. Grams +17 more
TL;DR: Outpatient potassium levels both above and below the normal range are consistently associated with adverse outcomes, with similar risk relationships across eGFR and albuminuria.
Journal ArticleDOI
Overview of regular dialysis treatment in Japan (as of 31 December 2008).
Shigeru Nakai,Kazuyuki Suzuki,Ikuto Masakane,Atsushi Wada,Noritomo Itami,Satoshi Ogata,Naoki Kimata,Takashi Shigematsu,Toshio Shinoda,Tetsuo Syouji,Masatomo Taniguchi,Kenji Tsuchida,Hidetomo Nakamoto,Shinichi Nishi,Hiroshi Nishi,Seiji Hashimoto,Takeshi Hasegawa,Norio Hanafusa,Takayuki Hamano,Naohiko Fujii,Seiji Marubayashi,Osamu Morita,Kunihiro Yamagata,Kenji Wakai,Yuzo Watanabe,Kunitoshi Iseki,Yoshiharu Tsubakihara +26 more
TL;DR: The risk of becoming HCV‐positive was high in patients with low serum creatinine, serum albumin, and serum total cholesterol levels, and/or a low body mass index before beginning dialysis, and the percentage is particularly high in Patients with a period of dialysis of 20 years or longer.
Journal ArticleDOI
Recovery Time, Quality of Life, and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Hugh C. Rayner,Lindsay Zepel,Douglas S. Fuller,Hal Morgenstern,Angelo Karaboyas,Bruce F. Culleton,Donna Mapes,Antonio Alberto Lopes,Brenda W. Gillespie,Takeshi Hasegawa,Rajiv Saran,Francesca Tentori,Manfred Hecking,Ronald L. Pisoni,Bruce M. Robinson +14 more
TL;DR: Recovery time can be used to identify patients with poorer HRQoL and higher risks of hospitalization and mortality and Interventions to reduce recovery time and possibly improve clinical outcomes, such as increasing dialysate sodium concentration, need to be tested in randomized trials.